异甘草酸镁对乳腺癌细胞系生物学行为的影响及作用机制
Effect and mechanism of magnesium isoglycyrrhizinate on the biological behavior of breast cancer cell lines

DOI: 10.6040/j.issn.1671-7554.0.2017.1038

Keywords: 乳腺癌,增殖,凋亡,MCF-7,异甘草酸镁,迁移,MDA-MB-231,
Magnesium isoglycyrrhizinate,Migration,MDA-MB-231,Breast cancer,Proliferation,Apoptosis,MCF-7

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Chen W, Zheng R, Badde PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2]	Nylandsted J, Brand K, J？？ttel？ M. Heat shock protein 70 is required for the survival of cancer cells [J]. Ann N Y Acad Sci, 2000, 926: 122-125.
[3]	Wei H, Wang C, Croce CM, et al. p62/SQSTM1 synergizes with autophagy for tumor growth in vivo [J]. Genes Dev, 2014, 28(11): 1204-1216.
[4]	Kim JM, Chen DS. Immune escape to PD-L1/PD-1 blockade: seven steps to success(or failure)[J]. Ann Oncol, 2016, 27(8): 1492-1504.
[5]	田青, 毕清, 赵明利. 异甘草酸镁治疗化疗药物性肝损害的临床疗效观察 [J]. 中国医药, 2012, 7(5): 588-590. TIAN Qing, BI Qing, ZHAO Mingli. Clinical control study of magnesium isoglycyrrhizinate in the treatment of liver function impairment caused by chemotherapy[J]. China Medicine, 2012, 7(5): 588-590.
[6]	Kumagai A, Nishino K, Shimomura A, et al. Effect of glycyrrhizin on estrogen action [J]. Endocrinol Jpn, 1967, 14(1): 34-38.
[7]	Prasad SJ, Farrand KJ, Matthews SA, et al. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells [J]. J Immunol, 2005, 174(1): 90-98.
[8]	Cierna Z, Mego M, Miskovska V, et al. Prognostic value of programmed-death-1 receptor(PD-1)and its ligand 1(PD-L1)in testicular germ cell tumors[J]. Ann Oncol, 2016, 27(2): 300-305.
[9]	Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion [J]. Nat Med, 2002, 8(8): 793-800.
[10]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.
[11]	孙黎, 曹惠明, 沈金芳,等. 静滴异甘草酸镁注射液的人体药代动力学研究 [J]. 中国药理学通报, 2005, 21(11): 1348-1351. SUN Li, CAO Huiming, SHEN Jinfang, et al. Study on the pharmacokinetics of magnesium isoglycyrrhizinate injections in Chinese healthy volunteers[J]. Chinese Pharmacological Bulletin, 2005, 21(11): 1348-1351.
[12]	Hibasami H, Iwase H, Yoshioka K, et al. Glycyrrhetic acid(a metabolic substance and aglycon of glycyrrhizin)induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells [J]. Int J Mol Med, 2006, 17(2): 215-219.
[13]	Huang RY, Chu YL, Jiang ZB, et al. Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase [J]. Cell Physiol Biochem, 2014, 33(2): 375-388.
[14]	Craig EA, Weissman JS, Horwich AL. Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell [J]. Cell, 1994, 78(3): 365-372.
[15]	Muenst S, Schaerli AR, Gao F, et al. Expression of programmed death ligand 1(PD-L1)is associated with poor prognosis in human breast cancer[J]. Breast Cancer Res Treat, 2014, 146(1): 15-24.
[16]	房澍名, 龚新雷, 秦叔逵. 新型甘草酸制剂防治抗肿瘤药物肝损伤的现状和进展[J]. 临床肿瘤学杂志, 2013, 18(9): 833-841. FANG Shuming, GONG Xinlei, QIN Shukui. Current situation and progression of new glycyrrhizin in the prevention and treatment of antineoplastic drug-induced liver injury [J]. Chinese Clinical Oncology, 2013, 18(9): 833-841.
[17]	Wu P, Wu D, Li L, et al. PD-L1 and survival in solid tumors: a Meta-analysis[J]. PLoS One, 2015, 10(6): e0131403. doi: 10.1371/journal.pone.0131403.
[18]	Velcheti V, Schalper KA, Carvajal DE, et al. Programmed death ligand-1 expression in non-small cell lung cancer[J]. Lab Invest, 2014, 94(1): 107-116.
[19]	Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy[J]. Nat Rev Cancer, 2012, 12(4): 252-264.
[20]	Rech AJ, Vonderheide RH. Dynamic interplay of oncogenes and T cells induces PD-L1 in the tumor microenvironment[J]. Cancer Discov, 2013, 3(12): 1330-1332.
[21]	Baptista MZ, Sarian LO, Derchain SF, et al. Prognostic significance of PD-L1 and PD-L2 in breast cancer [J]. Hum Pathol, 2016, 47(1): 78-84.
[22]	Robinson K, Lambiase L, LI J, et al. Fatal cholestatic liver failure associated with gemcitabine therapy[J]. Dig Dis Sci, 2003, 48(9): 1804-1808.
[23]	夏俊.异甘草酸镁在化疗后肝功能异常治疗中的临床应用[J]. 现代中西医结合杂志, 2012, 21(9): 958-959.
[24]	Price JT, Quinn JM, Sims NA, et al. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line [J]. Cancer Res, 2005, 65(11): 4929-4938.
[25]	Chowdhury S, Veyhl J, Jessa F, et al. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants[J]. Oncotarget, 2016, 7(22): 32318-32328.
[26]	Lin Z, Xu Y, Zhang Y, et al. The prevalence and clinicopathological features of programmed death-ligand 1(PD-L1)expression: a pooled analysis of literatures [J]. Oncotarget, 2016, 7(12): 15033-15046.

Full-Text